AORT (Artivion) Total Net Assets

Public company logo of artivion.com (AORT)

The Artivion, Inc. (AORT) price chart demonstrates the impact of ESG initiatives aimed at reducing manufacturing waste and energy consumption. The high cost of unique cardiac implants and physicians' price insensitivity maintain margins at 0.44. The business relies on the creation of bioprosthetic valves: following FDA approval, production costs decline, while global demand ensures stable revenue through patent scalability.

AORT CryoLife: Company Book Value in the range 07/04/2022 - 10/30/2026

Artivion - analytical breakdowns and key metrics (AORT)

- current price and projected stock value:
Price Performance Chart Artivion Corp|AORT - Consensus Target
- business market valuation indicators:
Market Value CryoLife|AORT - Total Company Value
- business book valuation details:
Net Assets per Share Artivion|AORT - Company Book Value|Market Capitalization to Net Assets artivion.com|AORT - Company Total Assets
- debt and liquidity data:
Debt to Capital Artivion, Inc.|AORT - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio CryoLife|AORT - Company Aggregate Debts|Debts to Net Assets CryoLife|AORT - Company Long-Term Debts|Company Short-Term Debts Artivion|Quick Liquidity artivion.com
- business earnings and investment ratios data:
AORT - Net Profit
Fundamental company valuation:AORT (Artivion Corp)
Core merchandise of Artivion Inc

This indicator reflects the total net asset value of Artivion, Inc. (AORT), calculated as the difference between all company assets and liabilities. By analyzing the company's balance sheet capitalization on the GURU.Markets platform, an investor assesses the business's internal reserves, which for this cardio-implant manufacturer are supported by stable demand for life-critical products and predictable cash flows.

Competitor analysis for Artivion, Inc.

Accounting Value of Company BSX (Boston Scientific Corporation Inc.)|EW (Edwards Lifesciences) - Company Net Assets|RMD: Total Net Assets|Company Book Value Insulet|Zimmer Biomet (ZBH) - Book Valuation of Business|Company Book Value CooperVision (COO)|ALGN: Net Asset Value|Book Capitalization GMED (Globus Medical, Inc.)|TransMedics Organ Care System (TMDX) - Total Stockholders' Equity|Alphatec - Book Capitalization|Enovis Corp (ENOV) - Company Net Assets|IART: Book Capitalization|ESTA - Book Valuation of Business|BBNX (Beta Bionics Inc) - Book Capitalization|Book Capitalization iradimed.com|Company Book Value Embecta (EMBC)|Company Book Value TNDM (Tandem Diabetes Care Inc)|Book Capitalization AXGN (Axogen Corp)|Book Valuation of Business SI-BONE Medical (SIBN)|OFIX: Company Net Assets|Net Asset Value BVS|KIDS: Book Capitalization|Total Stockholders' Equity Treace Medical Concepts Inc (TMCI)|SRTA (Strata Critical Medical Corp) - Book Capitalization|Accounting Capitalization CARL (Carlsmed Medical)|Company Net Assets RXST (RxSight, Inc.)|CLPT (clearpointneuro.com) - Accounting Value of Company|Company Book Value Stereotaxis STXS|STIM - Company Net Assets|Sight Sciences, Inc - Book Capitalization|Total Stockholders' Equity Orchestra BioMed Inc.|ANIK: Book Capitalization|Accounting Capitalization NSPR|ZJYL (Jin Medical International Ltd.) - Book Capitalization|Vivani (VANI) - Book Valuation of Business|Book Capitalization XTNT|Company Net Assets NeuroOne Medical Technologies Corp. NMTC|Book Capitalization MODD (Modular Medical, Inc.)|Book Capitalization myomo.com MYO|COCH - Company Book Value|VVOS: Company Book Value|NVNO (enVVeno) - Company Net Assets|Sintx Technologies, Inc. - Accounting Value of Company|TNON (Tenon Medical, Inc.) - Book Capitalization|Total Stockholders' Equity rewalk.com LFWD|Company Book Value Autonomix Medical, Inc. (AMIX)|INVO Bioscience (IVF) - Book Value of Business|Bone Biologics Corporation - Company Net Assets|Book Capitalization Axonics, Inc AXNX|BIOLASE, Inc. - Book Capitalization|Book Valuation of Business Dynatronics Corporation DYNT|paragon28.com (FNA) - Company Book Value|Net Asset Value INVO (INVO Bioscience)